Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal thrombocytopenia.

Subarna Chakravorty1, Neil Murray, Irene Roberts

  • 1Department of Haematology, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK.

Early Human Development
|February 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RPS19 and RPL5 haploinsufficient models reveal divergent ribosomal subunit controls of fetal hematopoiesis.

Nature communications·2026
Same author

Editorial: Unraveling inflammatory pathways in sickle cell disease: molecular, cellular and translational insights.

Frontiers in immunology·2026
Same author

Hematological Conditions in Infants With Trisomy 21.

NeoReviews·2025
Same author

Vaccination at a crossroad: science, politics and public trust.

Swiss medical weekly·2025
Same author

RPS19 and RPL5 Haploinsufficient Models Reveal Divergent Ribosomal Subunit Controls of Fetal Hematopoiesis.

Research square·2025
Same author

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Blood·2025

Neonatal thrombocytopenia, a common issue in intensive care units, presents differently in preterm and term infants. Further research is needed to establish optimal platelet transfusion guidelines for these vulnerable neonates.

Area of Science:

  • Neonatal Medicine
  • Hematology

Background:

  • Thrombocytopenia affects up to one-third of preterm neonates in intensive care units.
  • It presents as early-onset (within 72h, often mild, linked to placental issues) or late-onset (after 72h, often severe, linked to sepsis or necrotizing enterocolitis).
  • In term neonates, thrombocytopenia is typically severe, often caused by sepsis, perinatal asphyxia, or neonatal alloimmune thrombocytopenia.

Purpose of the Study:

  • To review the patterns and causes of neonatal thrombocytopenia.
  • To highlight the current lack of evidence-based treatment guidelines.
  • To emphasize the need for studies on optimal platelet transfusion strategies.

Main Methods:

  • Literature review and synthesis of existing data on neonatal thrombocytopenia.

Related Experiment Videos

  • Classification of thrombocytopenia based on onset and etiology in preterm and term neonates.
  • Identification of common causes and clinical presentations.

    • Main Results:

    • Early-onset thrombocytopenia in preterm neonates is generally mild and self-limiting, related to placental insufficiency.
    • Late-onset thrombocytopenia in preterm and thrombocytopenia in term neonates is often severe and associated with significant morbidities.
    • Bacterial sepsis, necrotizing enterocolitis, perinatal asphyxia, and neonatal alloimmune thrombocytopenia are key causes.

    Conclusions:

    • Neonatal thrombocytopenia requires careful differentiation between early and late onset in preterm infants and consideration of specific causes in term infants.
    • Current treatment strategies lack robust evidence, necessitating further research.
    • Optimal platelet transfusion protocols are crucial for improving outcomes in affected neonates.